Global Market Business Research Reports: July 2024

Wednesday, July 3, 2024

Global Head And Neck Cancer Therapeutics Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

Overview and Scope

Head and neck cancer therapeutics refer to the various treatment options and approaches to managing and combating head and neck cancers. The head and neck cancer therapeutics can benefit from precision of intensity modulated proton therapy. It also includes efficient therapies such as, surgery, radiation therapy, chemotherapy, certain medications, and immunotherapy.

Sizing and Forecast
The head and neck cancer therapeutics market size has grown rapidly in recent years. It will grow from $1.55 billion in 2023 to $1.73 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to tobacco and alcohol consumption, human papillomavirus (hpv) infections, environmental exposures, treatment modalities evolution.

The head and neck cancer therapeutics market size is expected to see rapid growth in the next few years. It will grow to $2.57 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to immunotherapy advances, precision medicine approaches, awareness and early diagnosis campaigns, global aging population. Major trends in the forecast period include expanding role of targeted therapies, adoption of minimally invasive surgical techniques, integration of palliative care, exploration of novel biomarkers, patient-centric care models.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-therapeutics-global-market-report

Segmentation & Regional Insights
The head and neck cancer therapeutics market covered in this report is segmented –
1) By Type: Programmed Cell Death (PD) Inhibitors, Microtubule Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors
2) By Route Of Administration: Injectable, Oral
3) By Distribution Channel: Retail And Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies
4) By Application: Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Other Applications

North America was the largest region in the head and neck cancer therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12426&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of head and neck cancer is expected to propel the growth of the head and neck cancer therapeutics market going forward. Head and neck cancer refers to a disease in which cells start growing uncontrollably in the tissues of the head and neck region. Increasing cases increase the need for better diagnosis and treatment to help treat mutations and cancer cell abnormalities. For instance, in 2023, according to Cancer Research UK, a UK-based independent cancer research organization, the incidence of head and neck cancer in the UK is projected to rise by 3% between 2023 and 2025, while deaths due to head and neck cancers are expected to increase by 12% between 2023 and 2025. Therefore, the increasing prevalence of head and neck cancer is driving the head and neck cancer therapeutics market.

Key Industry Players
Major companies operating in the head and neck cancer therapeutics market report are Pfizer Inc., F Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers-Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Incyte Corporation, Ono Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., Hikma Pharmaceuticals PLC, Clinigen Group plc., Ligand Pharmaceuticals, Acceleron Pharma Inc., Taiho Pharmaceutical Co. Ltd., Boston Biomedical Inc., AB Science SA.

The head and neck cancer therapeutics market report table of contents includes:
1. Executive Summary

2. Head And Neck Cancer Therapeutics Market Characteristics

3. Head And Neck Cancer Therapeutics Market Trends And Strategies

4. Head And Neck Cancer Therapeutics Market - Macro Economic Scenario

5. Global Head And Neck Cancer Therapeutics Market Size and Growth

32. Global Head And Neck Cancer Therapeutics Market Competitive Benchmarking

33. Global Head And Neck Cancer Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Head And Neck Cancer Therapeutics Market

35. Head And Neck Cancer Therapeutics Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Global Smoothies Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

Overview and Scope

A smoothie is a blended beverage typically made from a combination of fruits, vegetables, liquids such as juice or milk, and additional ingredients like yogurt, ice cream, or sweeteners. The ingredients ae blended until smooth, resulting in a thick, creamy, and often refreshing drink.

Sizing and Forecast
The smoothies market size has grown strongly in recent years. It will grow from $17.08 billion in 2023 to $18.44 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to health and wellness trends, rising awareness of nutrient-rich diets, demand for on-the-go and convenient nutrition, variety of flavor combinations, social media influence and food trends.

The smoothies market size is expected to see strong growth in the next few years. It will grow to $25.08 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to plant-based and vegan trends, innovations in functional ingredients, sustainable packaging and practices, expansion of ready-to-drink categories, personalization and customization trends. Major trends in the forecast period include focus on low sugar and natural sweeteners, e-commerce and delivery trends, sustainable packaging solutions, partnerships and collaborations, innovations in flavor combinations.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/smoothies-global-market-report

Segmentation & Regional Insights
The smoothies market covered in this report is segmented –
1) By Product Type: Fruit-Based, Vegetable-Based, Dairy-Based, Other Product Types
2) By Packaging Material: Plastic, Paper, Glass, Other Packaging Materials
3) By Distribution Channel: Supermarkets And Hypermarkets, Smoothie Bars, Convenience Stores, Other Distribution Channels

North America was the largest region in the smoothies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smoothies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12412&type=smp

Major Driver Impacting Market Growth
The increasing consumption of healthy beverages is expected to propel the growth of the smoothie market going forward. Healthy beverages provide beneficial nutrients and contribute to overall health and well-being. Smoothies are used as healthy beverages that provide a convenient and delicious way to consume a variety of fruits and vegetables, and with the addition of probiotics, they promote gut health and overall health and well-being. For instance, in 2021, according to the Government of Canada, a Canada-based government agency, the retail sales of energy drinks are expected to increase from US$14,150.4 million in 2020 to US$20,733.9 million in 2025. Additionally, the retail sales of fruit and vegetables increases from US$ 3,032.7 million in 2020 to US$3,532.0 in 2025 and the reduced sugar sports drinks increases from US$1,401.3 in 2020 to US$1,684.6 in 2025. Therefore, the increasing consumption of healthy beverages drives the smoothie market.

Key Industry Players
Major companies operating in the smoothies market report are PepsiCo Inc., The Coca-Cola Company, The Kraft Heinz Company, Danone S.A., The Hain Celestial Group Inc., Tropical Smoothie Café, MTY Food Group, Smoothie King Franchises Inc., Innocent Drinks, Bolthouse Farms, Cold Stone Creamery, Daily Harvest Inc., Odwalla, Bai Brands, Ella's Kitchen Brands Ltd., Jamba Juice Company, Boost Juice Bars , Suja Juice, Maui Wowi Hawaiian Coffees and Smoothies, Naked Juice, Crussh Fit Food & Juice Bars, Main Squeeze Juice Co., Revive Superfoods, Planet Smoothie, Dr.Smoothie, Barfresh Food Group Inc., Surf City Squeeze, Ceres Fruit Juices, Kwench Juice Cafe, Happy Planet Foods.

The smoothies market report table of contents includes:
1. Executive Summary

2. Smoothies Market Characteristics

3. Smoothies Market Trends And Strategies

4. Smoothies Market - Macro Economic Scenario

5. Global Smoothies Market Size and Growth

32. Global Smoothies Market Competitive Benchmarking

33. Global Smoothies Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smoothies Market

35. Smoothies Market Future Outlook and Potential Analysis

36. Appendix

Viral Vector Manufacturing Market Competitive Landscape 2024-2033 – Major Players and Strategies

Overview and Scope

Viral vector manufacturing refers to producing viral vectors, tools that deliver genetic material into cells. A viral vector is a tool for gene transfer that can manipulate a particular cell type or tissue to express therapeutic genes.

Sizing and Forecast
The viral vector manufacturing market size has grown exponentially in recent years. It will grow from $5.82 billion in 2023 to $7 billion in 2024 at a compound annual growth rate (CAGR) of 20.4%. The growth in the historic period can be attributed to growth in pipeline of gene therapies, clinical success and approvals, increased investment in biopharmaceuticals, increased prevalence of genetic disorders.

The viral vector manufacturing market size is expected to see exponential growth in the next few years. It will grow to $14.55 billion in 2028 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to expanding applications in oncology, global collaborations in gene therapy research, adoption of viral vectors in vaccine development, continued clinical trials and commercialization. Major trends in the forecast period include technological innovations in vector production, emergence of next-generation vectors, regulatory compliance and standardization, collaborations and partnerships, global expansion of manufacturing facilities.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Segmentation & Regional Insights
The viral vector manufacturing market covered in this report is segmented –
1) By Type: Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types
2) By Disease: Cancer, Genetic Disorders, Infectious Diseases, Other Diseases
3) By Workflow: Upstream Processing, Downstream Processing
4) By Application: Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research
5) By End-User: Research Organizations, Biotech And Pharmaceutical Companies, Others End Users

North America was the largest region in the viral vector manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12398&type=smp

Major Driver Impacting Market Growth
The increase in the prevalence of cancer and infectious diseases is expected to propel the growth of the viral vector manufacturing market going forward. An infectious disease refers to a condition brought on by a virus or its toxic byproduct and spread to a susceptible host via contact with an infected person, animal, or item. Cancer refers to a broad range of illnesses that can develop in any organ or tissue of the body when aberrant cells grow out of control, cross their usual boundaries to invade neighbouring organs, and spread to other organs. Tumor antigens, or proteins on tumor cells, are produced via viral vectors to elicit the body's anticancer immune response. In pre-clinical and clinical trials, viral vectors have served as vaccines against various infectious illnesses. For instance, in May 2022, according to the World Health Organization, a Switzerland-based specialized health agency, compared to 245 million cases in 2020, there were 247 million cases of malaria in 2021. Furthermore, in June 2023, according to the Centers for Disease Control and Prevention, a US-based Department of Health and Human Services, there were 1,603,844 new cancer cases and 602,347 cancer-related deaths in the US in 2020. Therefore, the increase in the prevalence of cancer and infectious diseases is driving the growth of the viral vector manufacturing market.

Key Industry Players
Major companies operating in the viral vector manufacturing market report are Sanofi S.A., Thermo Fisher Scientific Inc., Merck Group, FUJIFILM Holdings Corporation, Lonza Group, Catalent Inc., Sartorius AG, Charles River Laboratories International Inc., AGC Biologics, Ultragenyx Pharmaceutical Inc., Novasep Holding SAS, Aldevron LLC,Oxford Biomedica plc, REGENXBIO Inc., LakePharma Inc., Voyager Therapeutics Inc., Mustang Bio Inc., Regenxbio Inc., VGXI Inc., BioNTech IMFS GmbH, FinVector Oy, Vigene Biosciences Inc., Univercells Technologies, Sirion-Biotech GmbH, Cevec Pharmaceuticals GmbH, Batavia Biosciences BV.

The viral vector manufacturing market report table of contents includes:
1. Executive Summary

2. Viral Vector Manufacturing Market Characteristics

3. Viral Vector Manufacturing Market Trends And Strategies

4. Viral Vector Manufacturing Market - Macro Economic Scenario

5. Global Viral Vector Manufacturing Market Size and Growth

32. Global Viral Vector Manufacturing Market Competitive Benchmarking

33. Global Viral Vector Manufacturing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Viral Vector Manufacturing Market

35. Viral Vector Manufacturing Market Future Outlook and Potential Analysis

36. Appendix

Virgin Coconut Oil Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope

Virgin coconut oil (VCO) is made by cold pressing the coconut meat's liquid and then separating the oil from the milk and water. It is widely used as a nutritional supplement due to its potential health advantages.

Sizing and Forecast
The virgin coconut oil market size has grown strongly in recent years. It will grow from $2.25 billion in 2023 to $2.45 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to traditional and cultural usage, growing health consciousness, research on medium-chain triglycerides, alternative to trans fats, rising demand in western markets.

The virgin coconut oil market size is expected to see strong growth in the next few years. It will grow to $3.46 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to globalization of coconut products, rising demand for natural cosmetics, e-commerce expansion, increasing vegan and plant-based diets, growth in nutraceuticals industry. Major trends in the forecast period include extraction technologies advancements, innovations in packaging, sustainable and ethical sourcing and packaging, cbd-infused coconut oil products.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/virgin-coconut-oil-global-market-report

Segmentation & Regional Insights
The virgin coconut oil market covered in this report is segmented –
1) By Type: Organic, Conventional
2) By Distribution Channels: Offline, Online
3) By Application: Direct Consumption, Indirect Consumption, Food And Beverages, Cosmetics And Personal Care, Pharmaceuticals

Asia-Pacific was the largest region in the virgin coconut oil market in 2023. The regions covered in the virgin coconut oil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12149&type=smp

Major Driver Impacting Market Growth
Growing demand for functional foods is expected to propel the growth of the virgin coconut oil market going forward. Functional foods are broadly defined as processed foods that give medical or health benefits and reduce disease risk. Virgin coconut oil can be utilized as an ingredient in functional foods, such as functional beverages, nutritional spreads, dairy alternatives, baked goods, and snacks, to deliver its special health advantages and functional qualities. For instance, in October 2022, according to the New Zealand Trade and Enterprise Highlights, a New Zealand-based government agency, the functional beverage market in Australia was valued at $451 million at the beginning of 2022, and by the end of the year, it is risen by 2.8%. Furthermore, in 2023, according to the Department for Business and Trade, a UK-based government agency, the global market for functional foods was estimated to be worth 209.6-billion-pound sterling ($259.96 billion) in 2021, and from 2021 to 2028, it is expected to grow at a rate of 9.5%. Therefore, the growing demand for functional foods is driving the growth of the virgin coconut oil market.

Key Industry Players
Major companies operating in the virgin coconut oil market report are Archer-Daniels-Midland Company, The Hain Celestial Group, Dabur India Limited, Marico Ltd., Hain Celestial Group, NOW Foods Group Inc., Garden of Life LLC, Jarrow Formulas Inc, Nature's Plus, Edward and Sons Trading Company, Nutiva Inc., La Tourangelle, Kapiva, Barlean's Organic Oils LLC, Bioriginal Food & Science Corp, Jax Coco, Nutriorg, Healthy Traditions Inc., iTi Tropicals Inc., Celebes Coconut Corporation, Sun Bionaturals Private Ltd, Spectrum Organic Products LLC, SC Global Coco Products Inc., Greenville Agro Corporation, Viva Naturals, PT. Harvard Cocopro, Growrich Manufacturing Inc., WOW Skin Science, KLF Nirmal

The virgin coconut oil market report table of contents includes:
1. Executive Summary

2. Virgin Coconut Oil Market Characteristics

3. Virgin Coconut Oil Market Trends And Strategies

4. Virgin Coconut Oil Market - Macro Economic Scenario

5. Global Virgin Coconut Oil Market Size and Growth

32. Global Virgin Coconut Oil Market Competitive Benchmarking

33. Global Virgin Coconut Oil Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Virgin Coconut Oil Market

35. Virgin Coconut Oil Market Future Outlook and Potential Analysis

36. Appendix

Monday, July 1, 2024

Pharmaceutical Fill and Finish Outsourcing Market Growth Outlook Through 2024-2033

Overview and Scope

Pharmaceutical fill and finish outsourcing is the practice of contracting with specialized pharmaceutical manufacturing companies to offer pharmaceutical filling and sealing operations into end-use containers with appropriate sterility and accuracy. These services are utilized by pharmaceutical and biopharmaceutical companies for specialized people with experience, costly automated equipment acquisitions, stringent regulatory agency inspection, increased efficiency, and flexibility in terms of production capacity.

Sizing and Forecast
The pharmaceutical fill and finish outsourcing market size has grown strongly in recent years. It will grow from $3.25 billion in 2023 to $3.51 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to emergence of contract development and manufacturing organizations (cdmos, demand for specialized services, shift to outsourced models, market expansion strategies, stringent regulatory requirements..

The pharmaceutical fill and finish outsourcing market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to demand for specialized services, global market expansion, focus on core competencies, rapid market entry for new drugs, flexibility in manufacturing capacity: anticipated need for flexible manufacturing capacity to accommodate fluctuatio.. Major trends in the forecast period include increased biologics outsourcing, sustainability initiatives, geographic expansion of outsourcing hubs, technological integration for efficiency, rise in contract development and manufacturing organizations (cdmos)..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-fill-and-finish-outsourcing-global-market-report

Segmentation & Regional Insights
The pharmaceutical fill and finish outsourcing market covered in this report is segmented –
1) By State Of Finished Products: Liquid, Solids, Semi Solids
2) By Content: Organic Substances Isolated From Animal Origin, Organic Substances Isolated From Microorganisms, Inorganic Substances
3) By End-Users: Biopharmaceutical Companies, Pharmaceutical Companies

North America was the largest region in the pharmaceutical fill and finish outsourcing market in 2023. The regions covered in the pharmaceutical fill and finish outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12069&type=smp

Major Driver Impacting Market Growth
The rising demand for biologic drugs is expected to propel the growth of the pharmaceutical fill and finish outsourcing market going forward. Biologic drugs, also known as biologics or biosimilars, are a class of pharmaceutical products derived from living organisms or containing components of living organisms. Drug manufacturers can use the skills and infrastructure of contract manufacturing organizations (CMOs) by outsourcing the fill and finish phase of production, allowing pharmaceutical companies to focus on the development, research, and scale-up of their biologic drugs while relying on CMOs for efficient and cost-effective fill and finish operations. For instance, in September 2022, according to Association for Accessible Medicines (AAM), a US-based trade association for generic prescription drugs and pharmaceutical chemicals manufacturers, in 2021, people in the United States got 6.4 billion prescriptions, 91% of which were generic and biosimilar medications. Annual savings from generics and biosimilars have surpassed $373 billion, an increase of around $33 billion over 2020. Therefore, the rising demand for biologic drugs will the pharmaceutical fill and finish outsourcing market.

Key Industry Players
Major companies operating in the pharmaceutical fill and finish outsourcing market report are Groninger and Co. GmbH, Merck and Co.Inc., Abbott Laboratories, Wockhardt Limited., Boehringer Ingelheim International GmbH, Becton Dickinson and Company, AbbVie Inc., Teva Pharmaceuticals Industries Ltd., Recipharm AB., Lonza Group AG, Catalent Inc., Dr. Reddys Laboratories Ltd., West Pharmaceutical Services Inc., Sun Pharmaceutical Industries Ltd., Patheon N.V., Piramal Enterprises Ltd., Gerresheimer AG, CordenPharma International, Fujifilm Diosynth Biotechnologies, Optima Packaging Group GmbH, Jubilant HollisterStier LLC., Ajinomoto Bio-Pharma Services, Cytovance Biologics Inc., Grand River Aseptic Manufacturing, Baxter Pharmaceutical Solutions LLC., Halo Pharma Inc., MabPlex Inc., August Bioservices, Syntegon Technology GmbH (Robert Bosch GmbH), Ranbaxy Laboratories Limited.

The pharmaceutical fill and finish outsourcing market report table of contents includes:
1. Executive Summary

2. Pharmaceutical Fill and Finish Outsourcing Market Characteristics

3. Pharmaceutical Fill and Finish Outsourcing Market Trends And Strategies

4. Pharmaceutical Fill and Finish Outsourcing Market - Macro Economic Scenario

5. Global Pharmaceutical Fill and Finish Outsourcing Market Size and Growth

32. Global Pharmaceutical Fill and Finish Outsourcing Market Competitive Benchmarking

33. Global Pharmaceutical Fill and Finish Outsourcing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmaceutical Fill and Finish Outsourcing Market

35. Pharmaceutical Fill and Finish Outsourcing Market Future Outlook and Potential Analysis

36. Appendix

Ovarian Cancer Diagnostics Market Competitive Landscape 2024-2033 – Major Players and Strategies

Overview and Scope

Ovarian cancer diagnostics refers to the methods and procedures used to detect and diagnose ovarian cancer, including assessing symptoms, conducting physical examinations, and performing various diagnostic tests. Ovarian cancer is a malignant tumor that develops in the ovaries, which are part of the female reproductive system.

Sizing and Forecast
The ovarian cancer diagnostics market size has grown strongly in recent years. It will grow from $2.62 billion in 2023 to $2.82 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growth in biomarker discovery and validation, transvaginal ultrasound adoption, brca gene mutations awareness, research on tumor markers, screening programs and guidelines.

The ovarian cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to early detection initiatives, increasing incidence of ovarian cancer, integration of artificial intelligence (ai), personalized medicine approaches, emergence of novel biomarkers, genomic and proteomic profiling. Major trends in the forecast period include biosensor technologies for early detection, digital pathology integration, innovations in imaging modalities, improved imaging technologies, advancements in pathology techniques.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/ovarian-cancer-diagnostics-global-market-report

Segmentation & Regional Insights
The ovarian cancer diagnostics market covered in this report is segmented –
1) By Product Type: Instruments, Kits, Reagents
2) By Diagnosis Type: Biopsy, Blood Test, Imaging, Other Diagnosis Types
3) By Cancer Type: Epithelial Tumor, Germ Cell Tumor, Stromal Cell Tumor, Other Cancer Types
4) By End User: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes

North America was the largest region in the ovarian cancer diagnostic market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ovarian cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12022&type=smp

Major Driver Impacting Market Growth
The rise in the prevalence of ovarian cancer is expected to propel the growth of the ovarian cancer diagnostics market going forward. Ovarian cancer is a malignant tumor that develops in the ovaries, the female reproductive organs responsible for producing eggs and hormones. This shift has resulted from increased longevity, delayed childbearing, and lifestyle changes. Ovarian cancer diagnostics can help reduce the prevalence of ovarian cancer by enabling early detection and intervention, leading to timely treatment and improved outcomes. For instance, in February 2022, according to the World Ovarian Cancer Coalition, a Canada-based not-for-profit organization, ovarian cancer affected 313,959 women worldwide in 2020. This will have increased by 42% by 2040 to 445,721; between 2020 and 2040, there will be a 51% increase in the number of women dying from ovarian cancer, from 207,252 to 313,617. Therefore, the rising prevalence of ovarian cancer is driving the growth of the ovarian cancer diagnosis market.

Key Industry Players
Major companies operating in the ovarian cancer diagnostics market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Bio-rad Laboratories Inc., Qiagen N.V., Natera Inc., The American Cancer Society, Myriad Genetics Inc., ArcherDX Inc., Invitae Corporation, Guardant Health, Luminex Corporation, NanoString Technologies Inc., Siemens Healthcare Private Limited, Menarini Silicon Biosystems S.p.A., Precipio Inc., Angle plc

The ovarian cancer diagnostics market report table of contents includes:
1. Executive Summary

2. Ovarian Cancer Diagnostics Market Characteristics

3. Ovarian Cancer Diagnostics Market Trends And Strategies

4. Ovarian Cancer Diagnostics Market - Macro Economic Scenario

5. Global Ovarian Cancer Diagnostics Market Size and Growth

32. Global Ovarian Cancer Diagnostics Market Competitive Benchmarking

33. Global Ovarian Cancer Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Ovarian Cancer Diagnostics Market

35. Ovarian Cancer Diagnostics Market Future Outlook and Potential Analysis

36. Appendix

Non-thermal Pasteurization Market Competitive Landscape 2024-2033 – Major Players and Strategies

Overview and Scope

Non-thermal pasteurization refers to successfully killing or inactivating germs in foods and drinks that do not employ standard heat-based technologies. These techniques are used to increase the shelf life of processed food without affecting its nutritional value.

Sizing and Forecast
The non-thermal pasteurization market size has grown exponentially in recent years. It will grow from $1.88 billion in 2023 to $2.29 billion in 2024 at a compound annual growth rate (CAGR) of 22.2%. The growth in the historic period can be attributed to government support and funding for innovation, consumer education on food safety, increasing demand for ready-to-eat foods, industrialization of food production, cost efficiency and process optimization, .

The non-thermal pasteurization market size is expected to see exponential growth in the next few years. It will grow to $4.78 billion in 2028 at a compound annual growth rate (CAGR) of 20.1%. The growth in the forecast period can be attributed to market expansion strategies, environmental sustainability considerations, consumer concerns over chemical additives, rise in demand for plant-based and vegan foods, cost efficiency and process optimization, globalization of food trade.. Major trends in the forecast period include integration of pulsed electric field (pef) technology, market emphasis on high-pressure processing (hpp), growth in irradiation techniques, advancements in uv-c technology, adoption of microwave-assisted thermal sterilization (mats)..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/non-thermal-pasteurization-global-market-report

Segmentation & Regional Insights
The non-thermal pasteurization market covered in this report is segmented –
1) By Technique: High Pressure processing, Pulse electric field, Microwave volumetric heating, Ultrasonic, Irradiation, Other Techniques
2) By Form: Solid, Liquid
3) By Application: Food and Beverages, Pharmaceuticals, Cosmetics

North America was the largest region in the non-thermal pasteurization market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-thermal pasteurization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12046&type=smp

Major Driver Impacting Market Growth
The increasing number of instances related to foodborne diseases significantly contributes to the growth of the non-thermal pasteurization market going forward. Foodborne illnesses refer to any hazardous or infectious sicknesses from consuming contaminated water or food. Non-thermal pasteurization techniques kill or inactivate harmful microbes in food items that cause foodborne diseases. For instance, according to the report published by the World Health Organization (WHO), a Switzerland-based government agency responsible for international public health, 600 million individuals, or around one in ten people around the globe, suffer from foodborne illness, and 0.42 million people die yearly. Further, according to 2023 data released by the European Food Safety Authority (EFSA), an Italy-based government agency that provides independent scientific advice and communicates on existing and emerging risks, the number of foodborne outbreaks in the EU reached 4,005 in 2021, an increase of 29.8% from 2020. Therefore, increasing instances related to foodborne diseases will drive the non-thermal pasteurization market.

Key Industry Players
Major companies operating in the non-thermal pasteurization market report are Emerson Electric Co., GEA Group, Syntegon, JBT Corporation, Sterigenics International Inc., FresherTech, Bühler Holding AG, Nordion Inc., Thyssenkrupp AG, Universal Pure, Hiperbaric Espana, Bettcher Industries Inc., Avure Technologies Inc., MULTIVAC Group, Elea Technology GmbH, Chic Freshertech Co. Ltd., FENCO Food Machinery, AseptoRay, Bao Tou Kefa High Pressure Technology Co. Ltd., Suja Life LLC, Gray Star Inc., Ionisos SA, Sadex Corporation, BRIO Ultrasonics, SONIMAT

The non-thermal pasteurization market report table of contents includes:
1. Executive Summary

2. Non-thermal Pasteurization Market Characteristics

3. Non-thermal Pasteurization Market Trends And Strategies

4. Non-thermal Pasteurization Market - Macro Economic Scenario

5. Global Non-thermal Pasteurization Market Size and Growth

32. Global Non-thermal Pasteurization Market Competitive Benchmarking

33. Global Non-thermal Pasteurization Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Non-thermal Pasteurization Market

35. Non-thermal Pasteurization Market Future Outlook and Potential Analysis

36. Appendix

Myocardial Infarction Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope

Myocardial infarction is a potentially fatal disorder that develops when the heart muscle's blood supply is suddenly interrupted, resulting in tissue damage. Myocardial infarction is triggered by high levels of low-density lipoprotein in the blood, high blood pressure, and smoking.

Sizing and Forecast
The myocardial infarction market size has grown strongly in recent years. It will grow from $1.9 billion in 2023 to $2.04 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to introduction of beta-blockers, establishment of chest pain centers, thrombolytic therapies, enomic and personalized medicine approaches, wearable cardiovascular devices.

The myocardial infarction market size is expected to see strong growth in the next few years. It will grow to $2.68 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to global health initiatives for cardiovascular health, expanded access to reperfusion therapies, rna therapeutics for cardiovascular diseases, patient-centered care models, focus on microvascular dysfunction, bioelectronic medicine. Major trends in the forecast period include advancements in cardiovascular imaging, advancements in cardiac surgery techniques, advancements in telemedicine, integration of artificial intelligence in diagnosis, innovation of digital biomarkers for risk prediction, blockchain for healthcare data security, ai-driven drug discovery, innovations in cardiac rehabilitation technologies.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/myocardial-infarction-global-market-report

Segmentation & Regional Insights
The myocardial infarction market covered in this report is segmented –
1) By Drug Class: Antiplatelet Agents, Glycoprotein IIb/IIIa Inhibitors, Antithrombotic Agents, Beta-adrenergic Blockers, Vasodilators, Angiotensin-converting Enzyme (ACE) Inhibitors, Angiotensin-receptor Blockers, Analgesics, Thrombolytics
2) By Route Of Administration: Oral, Injectable
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

North America was the largest region in the myocardial infarction market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the myocardial infarction market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12164&type=smp

Major Driver Impacting Market Growth
An increasing number of smokers is expected to propel the growth of the myocardial infarction market going forward. A smoker is anyone who smokes cigarettes, cigars, or a pipe. Cigarette smoke contains chemicals that cause the blood to thicken and clot in veins and arteries, and a blockage brought on by a clot can result in myocardial infarction. For instance, in September 2023, according to the Office for National Statistics, a UK-based government department, the segment of the UK population aged 25 to 34 years maintained the highest percentage of current smokers, accounting for 16.3% or approximately 1.4 million individuals in 2022. This represents an increase from the previous year, when the same age group had a smoking prevalence of 15.8%, encompassing around 1.3 million people. Therefore, an increasing number of smokers is driving the growth of the myocardial infarction market.

Key Industry Players
Major companies operating in the myocardial infarction market report are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Boehringer Ingelheim GmbH, Merck KGaA, Daiichi Sankyo Co. Ltd., Bio-Rad Laboratories Inc., Apotex Inc., Siemens Healthcare Diagnostics Limited, Annexin Pharmaceuticals AB, Dynavax Technologies Corp, Heartseed Inc., Par Pharmaceutical Companies Inc., Tenaya Therapeutics Inc., Idorsia Pharmaceuticals Ltd., Acesion Pharma ApS, Applied Therapeutics Inc., Athersys Inc., Cardurion Pharmaceuticals Inc., Verve Therapeutics Inc., Serca Pharmaceuticals AS

The myocardial infarction market report table of contents includes:
1. Executive Summary

2. Myocardial Infarction Market Characteristics

3. Myocardial Infarction Market Trends And Strategies

4. Myocardial Infarction Market - Macro Economic Scenario

5. Global Myocardial Infarction Market Size and Growth

32. Global Myocardial Infarction Market Competitive Benchmarking

33. Global Myocardial Infarction Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Myocardial Infarction Market

35. Myocardial Infarction Market Future Outlook and Potential Analysis

36. Appendix

Global Generic Oncology Sterile Injectable Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

Overview and Scope

A generic oncology sterile injectable refers to a type of biologic drug with the same active ingredients as the branded version but with only the inactive contents of the drug being different. It is used to treat distinct types of cancer, such as breast, prostate, and colorectal.

Sizing and Forecast
The generic oncology sterile injectable market size has grown rapidly in recent years. It will grow from $15.68 billion in 2023 to $17.61 billion in 2024 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to patent expirations for branded oncology drugs, increasing prevalence of cancer, growing focus on cost-effective healthcare solutions, regulatory support for generic medications, expansion of generic pharmaceutical companies.

The generic oncology sterile injectable market size is expected to see rapid growth in the next few years. It will grow to $27.04 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing healthcare investments, adoption of biosimilars in oncology, expansion of oncology drug pipelines, rise in global cancer incidence, regulatory pathways for generic sterile injectables. Major trends in the forecast period include development of complex generic oncology drugs, increasing use of advanced manufacturing technologies, rise of personalized medicine in oncology, growing emphasis on biosimilar competition, integration of digital technologies in supply chain management.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/generic-oncology-sterile-injectable-global-market-report

Segmentation & Regional Insights
The generic oncology sterile injectable market covered in this report is segmented –
1) By Product: Chemotherapy, Antimetabolites, Plant Alkaloids, Antitumor Antibiotics, Other Products
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Disease Indication: Ovarian Cancer, Breast Cancer, Lung Cancer, Pancreatic Cancer, Other Indications

North America was the largest region in the generic oncology sterile injectable market in 2023. Asia-Pacific is expected to be the generic oncology sterile injectable market report during the fastest-growing region in the forecast period. The regions covered in the generic oncology sterile injectable market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12223&type=smp

Major Driver Impacting Market Growth
The rising prevalence of cancer is expected to propel the growth of the generic oncology sterile injectable market going forward. Cancer is a category of illnesses that can develop in any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. The surge in the prevalence of cancer is driven by smoking, radiation, cancer-causing substances (carcinogens), obesity, and gene mutations. Generic oncology sterile injectable products are used to shrink tumors and stop the growth of cancer cells. For instance, in 2023, according to the American Cancer Society Inc., a US-based non-profit health group, 1.9 million new cancer cases are expected to be diagnosed in the US, an increase compared to more than 1.8 million new cancer cases diagnosed in 2021. Therefore, the rising prevalence of cancer is driving the growth of the oncology sterile injectable market.

Key Industry Players
Major companies operating in the generic oncology sterile injectable market report are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., Sanofi S.A., AstraZeneca plc, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH, Fresenius Kabi AG, Sun Pharmaceutical Industries Inc., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals LLC, Lupin Limited, Zydus Lifesciences Limited, Nichi-Iko Pharmaceutical Co. Ltd., Biocon Ltd., Jubilant Pharmova Ltd., Gland Pharma Limited, Apotex Inc., Accord Healthcare Ltd.

The generic oncology sterile injectable market report table of contents includes:
1. Executive Summary

2. Generic Oncology Sterile Injectable Market Characteristics

3. Generic Oncology Sterile Injectable Market Trends And Strategies

4. Generic Oncology Sterile Injectable Market - Macro Economic Scenario

5. Global Generic Oncology Sterile Injectable Market Size and Growth

32. Global Generic Oncology Sterile Injectable Market Competitive Benchmarking

33. Global Generic Oncology Sterile Injectable Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Generic Oncology Sterile Injectable Market

35. Generic Oncology Sterile Injectable Market Future Outlook and Potential Analysis

36. Appendix

Global Market Business Research Reports

Wednesday, July 3, 2024

Global Head And Neck Cancer Therapeutics Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

Global Smoothies Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

Viral Vector Manufacturing Market Competitive Landscape 2024-2033 – Major Players and Strategies

Virgin Coconut Oil Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Monday, July 1, 2024

Pharmaceutical Fill and Finish Outsourcing Market Growth Outlook Through 2024-2033

Ovarian Cancer Diagnostics Market Competitive Landscape 2024-2033 – Major Players and Strategies

Non-thermal Pasteurization Market Competitive Landscape 2024-2033 – Major Players and Strategies

Myocardial Infarction Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Global Generic Oncology Sterile Injectable Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

Global Head And Neck Cancer Therapeutics Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

Report Abuse

Labels